News
Remepy's hybrid Parkinson's therapy poised for phase 3
Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital
Sponsored
Discover a new era of healthcare panel engagement: Grounded ...
A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
Deep Dive
Why pharma needs honest patient dialogue
Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.
R&D
Sponsored
From Alzheimer’s disease research to the real-world setting:...
In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.
Patients
The cardio-renal-metabolic space and obesity as a chronic di...
The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.
Sales & Marketing
Sponsored
What HCPs Say Pharma Gets Wrong About Survey Research
Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.
R&D
Partner Content
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
Category :
Views & Analysis
/
Clinical